Celldex Therapeutics buy Citigroup Inc.
Start price
20.08.25
/
50%
€18.40
Target price
20.08.26
€41.27
Performance (%)
1.63%
Price
25.08.25
€18.90
Summary
This prediction is currently active. With a performance of 1.63%, the BUY prediction by Citigroup_Inc_ for Celldex Therapeutics is trending in the right direction. This prediction currently runs until 20.08.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 1.63% |
| iShares Core DAX® | -0.545% |
| iShares Nasdaq 100 | 0.626% |
| iShares Nikkei 225® | -1.750% |
| iShares S&P 500 | 0.882% |
Comments by Citigroup_Inc_ for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (NASDAQ:CLDX) had its price target lowered by analysts at Citigroup Inc. from $56.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€28.20
07.10.24
07.10.24
€63.74
07.10.25
07.10.25
-33.69%
25.08.25
25.08.25
